Início
Mercados
Gráficos e ideias
Algo
Notícias
Market
Corretoras
Baixar
Calendário econômico
Sinais de Negociação
Terminal web
Mapa de calor
Pressione
/
para pesquisar: @user, $symbol, ...
Pesquisar
Login
Criar uma conta
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
F
FHLC
Fidelity MSCI Health Care Index ETF
72.2
8
USD
-0.76%
Setor:
Finanças
Base:
USD
Moeda do lucro:
USD
Faixa diária
Faixa anual
Mudança diária
-0.76%
Mudança mensal
+3.85%
Mudança em 6 meses
-4.40%
Mudança anual
+16.28%
Fechamento anterior
72.8
3
Open
72.2
0
Mínimo
72.1
9
High
72.3
0
Volume
43
Mercados
US ETFs
FHLC
Abrir gráfico completo
Full chart
Visão geral
Todos os ativos
Mapa de calor
Principais ativos
Market Value
Shares
Weight %
DNA
Ginkgo Bioworks Holdings Inc
115.874460000 K
12.918000000 K
0.004098095%
ARDT
Ardent Health Inc
100.850480000 K
12.344000000 K
0.003566746%
GDRX
GoodRx Holdings Inc
89.319960000 K
39.348000000 K
0.003158950%
LENZ
LENZ Therapeutics Inc
79.716980000 K
5 039.000000000
0.002819325%
CTEV
Claritev Corp
67.465440000 K
2 484.000000000
0.002386028%
Chicago Mercantile Exchange
4 696.990000000
4.000000000
0.000166117%
CONTRA AKOUOS INC
2 253.970000000
11.863000000 K
0.000079715%
OMNIAB INC
1 567.450000000
3 335.000000000
0.000055435%
CONTRA CHINOOK THERAPE
0.240000000
24.218000000 K
0.000000008%
CONTRA AKERO THERAPEUT
0.220000000
22.341000000 K
0.000000008%
1
...
10
11
12
13
14
15
16
17
Notícias
First Quarter Earnings: Sharpening Sector Divergence
3 Reasons To Stick With Growth Stocks In Rotating Markets
Seeking Innovation Beyond Tech? Insight On Healthcare Stocks
Makary's Successor Faces Tough Task Managing FDA Amid Budget Cuts
Should You Invest in the Fidelity MSCI Health Care Index ETF (FHLC)?
What's The Dominant Trend In Earnings: AI Or Geopolitics?
Medical Technology Stocks: Innovation Endures As Valuations Reset
Trump's Psychedelics Stance Reignites Sector - How Investors Can Benefit
AI And The Future Of Healthcare
Global PMI: Tracking The Sectors Hit Hardest By The Middle East War
Can Forgotten Biotech Break Out?
Concerns Shift From Obsolescence To Oil